MYOREGENX Trademark

Trademark Overview

On Monday, August 2, 2021, a trademark application was filed for MYOREGENX with the United States Patent and Trademark Office. The USPTO has given the MYOREGENX trademark a serial number of 90860248. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, October 24, 2023. This trademark is owned by Satellos Bioscience Inc.. The MYOREGENX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

platform as a service (PAAS) featuring computer software platforms for muscle stem cell screening used to track and identify the divisions of individual muscle stem cells in response to various stimuli; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry; medical research
myoregenx

General Information

Serial Number90860248
Word MarkMYOREGENX
Filing DateMonday, August 2, 2021
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, October 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesplatform as a service (PAAS) featuring computer software platforms for muscle stem cell screening used to track and identify the divisions of individual muscle stem cells in response to various stimuli; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry; medical research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 28, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSatellos Bioscience Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto M5J2J3
CA

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 24, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 24, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, October 24, 2023SUSPENSION LETTER WRITTEN
Monday, October 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 14, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, May 30, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, May 30, 2023INQUIRY TO SUSPENSION E-MAILED
Tuesday, May 30, 2023SUSPENSION INQUIRY WRITTEN
Wednesday, November 30, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 30, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, November 30, 2022SUSPENSION LETTER WRITTEN
Wednesday, November 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 9, 2022NON-FINAL ACTION E-MAILED
Monday, May 9, 2022NON-FINAL ACTION WRITTEN
Friday, April 29, 2022ASSIGNED TO EXAMINER
Tuesday, September 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 5, 2021NEW APPLICATION ENTERED

Related Keywords

myoregenx stem muscle research stimuli various response cells scientific medical pharmacology